Related Experiment Video
Updated: Jan 28, 2026

06:41
Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
Published on: May 19, 2023
2.6K
Ultra-High-Frequency Reprogramming of Individual Long-Term Hematopoietic Stem Cells Yields Low Somatic Variant
Kai Wang1, Anthony K Guzman2, Zi Yan1
1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY.
Cell Reports
|March 7, 2019
Summary
Adult human long-term hematopoietic stem cells (LT-HSCs) can be reprogrammed into induced pluripotent stem cells (iPSCs) with high efficiency. These LT-HSCs may be ideal for generating clinical-grade iPSCs.
Area of Science:
- Stem cell biology
- Cellular reprogramming
- Hematopoiesis
Background:
- Reprogramming adult human cells into induced pluripotent stem cells (iPSCs) is crucial for regenerative medicine but has low efficiency.
- Identifying cell types amenable to efficient reprogramming is essential for clinical applications.
Purpose of the Study:
- To investigate the reprogramming efficiency of adult human long-term hematopoietic stem cells (LT-HSCs).
- To compare the genetic stability and mutation load of LT-HSCs versus skin fibroblasts for iPSC generation.
Main Methods:
- Senadi virus transduction of isolated CD49f+ LT-HSCs.
- Analysis of reprogramming efficiency across different hematopoietic progenitor stages.
- Whole-genome sequencing and mutation analysis of paired LT-HSC and fibroblast samples.
Main Results:
- Individual adult human LT-HSCs can be reprogrammed into iPSCs with nearly 50% efficiency.
- Reprogramming efficiency decreases significantly in more committed hematopoietic progenitors.
- LT-HSCs possess a lower load of somatic single-nucleotide variants (SNVs) and indels compared to skin fibroblasts.
- LT-HSCs and fibroblasts exhibit distinct somatic mutation signatures, with most mutations predating reprogramming.
Conclusions:
- LT-HSCs demonstrate exceptional susceptibility to reprogramming, surpassing other cell types.
- The lower mutation burden and distinct mutational profile of LT-HSCs make them a promising source for clinical-grade iPSC production.
- Optimizing reprogramming protocols, particularly cell cycle status, can further enhance efficiency.
Related Concept Videos
Induced Pluripotent Stem Cells
28.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K
Induced Pluripotent Stem Cells
5.5K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.5K
Multipotency of Hematopoietic Stem Cells
3.9K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.9K
Regulation of Hematopoietic Stem Cells
4.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.1K
Embryonic Stem Cells
32.3K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.3K
Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K

